NO983860L - Nye triazolopuriner, fremgangsmÕte for deres fremstilling og deres anvendelse som legemidler - Google Patents
Nye triazolopuriner, fremgangsmÕte for deres fremstilling og deres anvendelse som legemidlerInfo
- Publication number
- NO983860L NO983860L NO983860A NO983860A NO983860L NO 983860 L NO983860 L NO 983860L NO 983860 A NO983860 A NO 983860A NO 983860 A NO983860 A NO 983860A NO 983860 L NO983860 L NO 983860L
- Authority
- NO
- Norway
- Prior art keywords
- triazolopurins
- drugs
- novel
- preparation
- receptors
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 102000009346 Adenosine receptors Human genes 0.000 abstract 2
- 108050000203 Adenosine receptors Proteins 0.000 abstract 2
- 230000004913 activation Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 239000000296 purinergic P1 receptor antagonist Substances 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19629378A DE19629378A1 (de) | 1996-07-20 | 1996-07-20 | Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PCT/EP1997/003841 WO1998003511A1 (de) | 1996-07-20 | 1997-07-17 | Neue triazolopurine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| CA002242097A CA2242097C (en) | 1996-07-20 | 1998-06-26 | Imidazotriazolopyrimidines, process for preparing them and their use as pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983860D0 NO983860D0 (no) | 1998-08-21 |
| NO983860L true NO983860L (no) | 1998-10-21 |
Family
ID=32963000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983860A NO983860L (no) | 1996-07-20 | 1998-08-21 | Nye triazolopuriner, fremgangsmÕte for deres fremstilling og deres anvendelse som legemidler |
Country Status (25)
| Country | Link |
|---|---|
| EP (2) | EP0978517A3 (sk) |
| JP (1) | JP3020281B2 (sk) |
| CN (1) | CN1219936A (sk) |
| AT (1) | ATE191913T1 (sk) |
| AU (1) | AU3695597A (sk) |
| BG (1) | BG102707A (sk) |
| BR (1) | BR9710747A (sk) |
| CA (1) | CA2256736A1 (sk) |
| CZ (1) | CZ265498A3 (sk) |
| DE (2) | DE19629378A1 (sk) |
| DK (1) | DK0880524T3 (sk) |
| EE (1) | EE9800451A (sk) |
| ES (1) | ES2147453T3 (sk) |
| GR (1) | GR3033842T3 (sk) |
| HR (1) | HRP970395A2 (sk) |
| HU (1) | HUP9902311A3 (sk) |
| ID (1) | ID19106A (sk) |
| IL (1) | IL126453A0 (sk) |
| NO (1) | NO983860L (sk) |
| PL (1) | PL328824A1 (sk) |
| PT (1) | PT880524E (sk) |
| SK (1) | SK114498A3 (sk) |
| TR (1) | TR199801659T2 (sk) |
| WO (1) | WO1998003511A1 (sk) |
| ZA (1) | ZA976331B (sk) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19826843A1 (de) * | 1998-06-16 | 1999-12-23 | Boehringer Ingelheim Pharma | Neue Imidazotriazolopyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US6492377B1 (en) | 1998-06-25 | 2002-12-10 | Boehringer Ingelheim Pharma Kg | Imidazotriazolopyrimidines with adenosine-antagonistic activity |
| AU9347498A (en) * | 1998-08-27 | 2000-03-21 | Boehringer Ingelheim Pharma Kg | Imidazotriazolopyrimidines |
| WO2004075846A2 (en) | 2003-02-25 | 2004-09-10 | Bristol-Myers Squibb Company | Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| US7071333B2 (en) | 2003-07-30 | 2006-07-04 | Bristol-Myers Squibb Company | Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| BRPI0713619A2 (pt) | 2006-06-23 | 2013-01-15 | Incyte Corp | composto ou prà-droga ou sal farmaceuticamente aceitÁvel do mesmo, composiÇço, e, uso do composto. |
| AU2019227607C1 (en) | 2018-02-27 | 2023-07-20 | Incyte Corporation | Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors |
| JP7391046B2 (ja) | 2018-05-18 | 2023-12-04 | インサイト・コーポレイション | Ａ２ａ／ａ２ｂ阻害剤としての縮合ピリミジン誘導体 |
| TWI829857B (zh) | 2019-01-29 | 2024-01-21 | 美商英塞特公司 | 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU623755B2 (en) * | 1989-03-29 | 1992-05-21 | Merrell Pharmaceuticals Inc. | Selective adenosine receptor compounds |
| IT1264901B1 (it) * | 1993-06-29 | 1996-10-17 | Schering Plough S P A | Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina |
| JPH083169A (ja) * | 1994-06-15 | 1996-01-09 | Yamasa Shoyu Co Ltd | ４−メチル−１Ｈ−［１，２，４］トリアゾロ［１，５−ａ］プリン−９（４Ｈ）−オン類 |
-
1996
- 1996-07-20 DE DE19629378A patent/DE19629378A1/de not_active Withdrawn
-
1997
- 1997-07-17 PT PT97933683T patent/PT880524E/pt unknown
- 1997-07-17 DE DE59701467T patent/DE59701467D1/de not_active Expired - Lifetime
- 1997-07-17 BR BR9710747A patent/BR9710747A/pt unknown
- 1997-07-17 JP JP10505626A patent/JP3020281B2/ja not_active Expired - Fee Related
- 1997-07-17 SK SK1144-98A patent/SK114498A3/sk unknown
- 1997-07-17 PL PL97328824A patent/PL328824A1/xx unknown
- 1997-07-17 TR TR1998/01659T patent/TR199801659T2/xx unknown
- 1997-07-17 CZ CZ982654A patent/CZ265498A3/cs unknown
- 1997-07-17 AT AT97933683T patent/ATE191913T1/de active
- 1997-07-17 AU AU36955/97A patent/AU3695597A/en not_active Abandoned
- 1997-07-17 CA CA002256736A patent/CA2256736A1/en not_active Abandoned
- 1997-07-17 EE EE9800451A patent/EE9800451A/xx unknown
- 1997-07-17 ZA ZA976331A patent/ZA976331B/xx unknown
- 1997-07-17 WO PCT/EP1997/003841 patent/WO1998003511A1/de not_active Application Discontinuation
- 1997-07-17 EP EP99119410A patent/EP0978517A3/de not_active Withdrawn
- 1997-07-17 HU HU9902311A patent/HUP9902311A3/hu unknown
- 1997-07-17 ES ES97933683T patent/ES2147453T3/es not_active Expired - Lifetime
- 1997-07-17 DK DK97933683T patent/DK0880524T3/da active
- 1997-07-17 EP EP97933683A patent/EP0880524B1/de not_active Expired - Lifetime
- 1997-07-17 CN CN97194506A patent/CN1219936A/zh active Pending
- 1997-07-17 IL IL12645397A patent/IL126453A0/xx unknown
- 1997-07-18 ID IDP972495A patent/ID19106A/id unknown
- 1997-07-18 HR HR19629378.2A patent/HRP970395A2/hr not_active Application Discontinuation
-
1998
- 1998-08-20 BG BG102707A patent/BG102707A/xx active Pending
- 1998-08-21 NO NO983860A patent/NO983860L/no not_active Application Discontinuation
-
2000
- 2000-06-30 GR GR20000401543T patent/GR3033842T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP970395A2 (en) | 1998-08-31 |
| CA2256736A1 (en) | 1998-01-29 |
| JP3020281B2 (ja) | 2000-03-15 |
| NO983860D0 (no) | 1998-08-21 |
| DK0880524T3 (da) | 2000-07-17 |
| EP0880524B1 (de) | 2000-04-19 |
| AU3695597A (en) | 1998-02-10 |
| DE19629378A1 (de) | 1998-01-29 |
| CZ265498A3 (cs) | 1998-12-16 |
| PT880524E (pt) | 2000-07-31 |
| ZA976331B (en) | 1999-01-25 |
| EE9800451A (et) | 1999-06-15 |
| JP2000501420A (ja) | 2000-02-08 |
| HUP9902311A3 (en) | 2000-06-28 |
| ES2147453T3 (es) | 2000-09-01 |
| EP0978517A3 (de) | 2003-11-12 |
| EP0978517A2 (de) | 2000-02-09 |
| SK114498A3 (en) | 1999-02-11 |
| ATE191913T1 (de) | 2000-05-15 |
| CN1219936A (zh) | 1999-06-16 |
| BR9710747A (pt) | 1999-08-17 |
| ID19106A (id) | 1998-06-18 |
| WO1998003511A1 (de) | 1998-01-29 |
| BG102707A (en) | 1999-09-30 |
| EP0880524A1 (de) | 1998-12-02 |
| TR199801659T2 (xx) | 1998-12-21 |
| IL126453A0 (en) | 1999-08-17 |
| PL328824A1 (en) | 1999-02-15 |
| HUP9902311A2 (hu) | 1999-10-28 |
| GR3033842T3 (en) | 2000-10-31 |
| DE59701467D1 (de) | 2000-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200101859T2 (tr) | Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler | |
| FI905958A0 (fi) | Foerfarande foer framstaellning av substituerade cyklohexanoler, som verkar pao det centrala nervsystemet. | |
| NO992400L (no) | Nye substituerte pyrazolderivater | |
| BR0209580A (pt) | Derivados de ciclohexan-1, 4 diamina substituìdos | |
| BR0116452A (pt) | Composto, composição farmacêutica, uso de um composto | |
| ES2056214T3 (es) | Compuestos de benzopirido-piperidina, -piperidilideno y -piperazina, composiciones, metodos de preparacion y metodos de uso. | |
| BRPI9811688B1 (pt) | benzamidas bicìclicas gastrocinéticas de derivados de piperidina 3- ou 4- substituìdos com 4-aminometil), processo para preparação das mesmas, composições farmacêuticas compreendendo as mesmas e processo para preparação das referidas composições. | |
| DK0923554T3 (da) | N-Benzylpiperidin- og tetrahydropyridinderivater | |
| NO20021859D0 (no) | Nye digosakkarider, deres fremstilling samt farmasöytiske preparater | |
| NO963850L (no) | Heterosykliske forbindelser, deres fremstilling og anvendelse | |
| CA2094702A1 (en) | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents | |
| WO1992007832A3 (en) | Substituted piperazines as central nervous system agents | |
| NO971625L (no) | Nye peptider med immunomodulatoriske effekter | |
| BR0211739A (pt) | Novas formas polimórficas cristalinas de cloridrato de lercanidipina e processo para preparação das mesmas | |
| NO983860L (no) | Nye triazolopuriner, fremgangsmÕte for deres fremstilling og deres anvendelse som legemidler | |
| ATE251638T1 (de) | 2-substituierte nukleosid- und oligonukleotid- derivate | |
| NO975028L (no) | Piperazinoderivater som neurokininantagonister | |
| NO963331L (no) | 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister | |
| FI905957A0 (fi) | Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet. | |
| TR200001080T2 (tr) | 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri | |
| NO20000423D0 (no) | Tiazolobenzoheterocykler, deres fremstilling samt medikamenter inneholdende forbindelsene | |
| DK0767783T3 (da) | Substituerede alkyldiaminderivater og deres anvendelse som tachykinin-antagonister | |
| SE9803107D0 (sv) | Novel Compunds | |
| CO5150221A1 (es) | Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas | |
| TR200402685T4 (tr) | Merkezi sinir sistemi üzerine etki eden siklobüta-indol karboksamid türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |